Fundacion Dominicana de Perinatologia Pro Bebe

Hospital Universitario Maternidad Nuestra Senora de la Altagracia

Gastroenteritis

COVID-19

CureVac

HilleVax

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

This is a randomized, placebo-controlled study that is being done to evaluate the safety and effectiveness of two doses of the HIL-214 vaccine compared to a placebo. The study will enroll 3000 children who will be 5 months of age at the time of the first dose study vaccine. The second dose of study vaccine will be given 28 days after the first dose.

Efficacy and Safety of Two Doses of HIL-214 in Children

Hospital Universitario Maternidad Nuestra Senora de la Altagracia | Fundacion Dominicana de Perinatologia Pro Bebe

Site insights

Work at this site?

Active trials

Efficacy and Safety of Two Doses of HIL-214 in Children

Trial sponsors